OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← Infection Prevention Society

2025-03-31-accounts

Company Registration No: 06273843 Charity No: 1120063

Infection Prevention Society Company Limited by Guarantee

Trustees’ report and financial statements for the year ended 31 March 2025

Infection Prevention Society Company limited by guarantee

Page
Trustees’ annual report 2
Independent auditors’ report to the trustees 12
Statement of financial activities (incorporating the
income and expenditure account) 16
Balance sheet 17
Statement of cash flows 18
Accounting policies 19
Notes to the financial statements 22

Page 1

Infection Prevention Society Trustees’ annual report

The trustees of Infection Prevention Society (the “Society”) who are also Directors of the company for the purposes of the Companies Act 2006, present their annual report and financial statements for the year ended 31 March 2025.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies’ exemption, which includes an exemption from preparing a Strategic Report.

References and administrative details

Registered charity name Infection Prevention Society
Charity registration number 1120063
Company registration number 06273843
Registered office 71 Queen Victoria Street
London
EC4V 4BE
Auditors Saffery LLP
9 Haymarket Square
Edinburgh
EH3 8RY
Bankers Royal Bank of Scotland
36 St Andrew Square
Edinburgh
EH2 2YB
The Co-operative Bank
PO Box 250
Skelmersdale
WN8 6WT
Investment managers Rathbones (incorporating Investec Wealth & Investment (UK))
The Senate
Southernhay Gardens
Exeter
EX1 1UG
King & Shaxson Asset Management
Ethical Fund Management
155 Fenchurch Street
London
EC3M 6AL

Our governance

Governing document

The Infection Prevention Society is a charitable company limited by guarantee, incorporated on 8 June 2007 and registered as a charity on 12 July 2007. The company was established under a Memorandum of Association, which established the objects of the charity; these are to promote the advancement of education in infection prevention and control (IPC) for the benefit of the whole community. The Articles of Association were re-written and accepted by the membership on the 7 March 2020. The Trustees confirm the Society’s governance requirements, as company and a charity, have been met for 2025.

An update to the Articles of Association were approved by the member at an Extraordinary General Meeting in June 2024. This update allowed the number of Trustees to be increased in order to meet an overall objective of increasing the diversity and skill set of the Board of Trustees.

Page 2

Infection Prevention Society Trustees’ annual report

Organisational structure and decision-making process

The business of the Society is conducted by the Board of Trustees (BoT), which meets quarterly. BoT determines the strategy of the Society and reviews progress against its strategic aims and objectives.

The Chief Executive Officer manages the day-to-day operational decisions of the society.

Appointment of Trustees

The governance structure of IPS permits Trustee appointments from both inside and outside the membership to ensure the board has the relevant skills (such as management, finance, marketing and strategy) required to run the organisation effectively.

Trustees and Directors

Steven Hams (Chair, Independent Trustee) Virginia Edwards (Independent Trustee), term of office ended 30 September 2025 Andrew Leary (Independent Trustee), term of office ended 31 March 2025 Tracey Cooper (Member Trustee), term of office ended 18 June 2025 Carole Fry (Member Trustee) Lisa Butcher (President and Trustee, term of office ended 30 September 2024) Claire Hayward (Treasurer and Trustee, term of office ended 30 September 2024) Joanne Reynard (Secretary and Trustee, term of office ended 30 September 2024) Judith Robinson (President and Trustee, term of office started 30 September 2024 Sally Palmer (Treasurer and Trustee, term of office started 30 September 2024) Preety Ramdut (Independent Trustee, term of office started 4 November 2024) Tracey Gauci (Member Trustee, term of office started 14 November 2024) Kay Miller (Independent Trustee, term of office started 30 November 2024) Elizabeth Poskitt (Independent Trustee, appointed 1 April 2025

Karen Williams, (Member Trustee), term of office started 27 June 2025 Maura Smiddy, (Member Trustee), term of office started 27 June 2025

Co-opted Board Members

Karen Williams (term of office started 30 September 2024, term of office ended 26 June 2025) Co-opted Board Members are not Trustees and hold no voting rights

Key Management Personnel

Dr Alexander Rhys (Chief Executive Officer, started 1 August 2024)

Board of Trustees

The IPS BoT members serves as both directors of the Society for the purposes of the Companies Act and Trustees for the purposes of the Charities Act, three of whom are elected and six of who are appointed.

On the 5 June 2024, the membership voted to update the Articles of Association which allowed for the removal of the Honorary roles. There is no longer a Secretary role.

The 11 members of the Board are:

Board members have an equal vote and serve for a period of 3 years, with the exception of the President and Treasurer who serve for a period of 2 years.

The Board holds quarterly virtual meetings, with additional virtual meetings held in between as and when required.

Page 3

Infection Prevention Society Trustees’ annual report

The Board of Trustees oversee the business and assets of the IPS and act in accordance with the IPS governing document, (Articles of Association). Strategic decision-making is the responsibility of the Board of Trustees

Audit and Finance Committee (AFC)

The AFC scrutinise the annual budget and reports and make a recommendation to the Board of Trustees on risk, internal control and financial governance.

The AFC holds quarterly virtual meetings, with additional virtual meetings held in between as and when required.

A new Finance Trustee, and Chair of the Audit and Finance Committee, was appointed on the 1 April 2025.

Staff team

The Chief Executive Officer is responsible for the day-to-day operational decisions. Along with the staff team, they implement and manage the business activity of IPS in accordance with the strategic objectives and business plans and on behalf of the Board of Trustees.

Clinical Leadership and Engagement Committee (CLEC)

Following the introduction of the staff team, the Management Executive Group (MEG) transitioned to the Clinical and Leadership Engagement Committee (CLEC). CLEC is made up of representatives from branches, special interest groups, business groups along with the President, Vice President, Treasurer and CEO. CLEC serves as an advisory body that provides insights, perspectives, and recommendations on behalf of the IPS membership to the Board of Trustees and CEO. Whilst they have no executive powers, they play a critical role in ensuring that the strategic decisions made by IPS are informed by the knowledge and leadership of members working across diverse sectors in infection prevention.

Corporate Advisory Group (CAG)

The Corporate Advisory Group (CAG) provides a robust and effective foundation upon which to conduct relations with IPS corporate members and also to promote membership of the Society to new members. The IPS Board and MEG has consistently acknowledged the outstanding contribution made by corporate members to the well-being of the Society given their support at national and branch levels. The Board has therefore been pleased to facilitate the CAG and its programmes which sustain and enrich this relationship.

Editorial Management Group (EMG)

The EMG focuses on publishing a high-quality peer reviewed publication, the Journal of Infection Prevention, which advances professional knowledge and skill in the art and science of IPC practice. The EMG is responsible for supporting the publication of high-quality original papers and increasing the profile of the journal.

Education and Professional Development Committee (EPDC)

The EPDC focuses on developing and supporting the education and professional development of members and the advancement of infection prevention knowledge in the wider healthcare and education sectors. This is achieved by the development of resources and collaborative working and competency-based education activities.

Research and Development Group (R&D)

The R&D Committee focuses on building research capability and capacity among the IPS membership through education, initiating collaborative research projects and awarding annual research grants. In addition, they work with other external groups to further the evidence base for infection prevention and control.

Page 4

Infection Prevention Society Trustees’ annual report

Scientific Programme Committee (SPC)

The SPC focuses on creating robust and topical scientific programmes for the IPS annual conference and works in parallel with our professional conference organiser, to deliver a high quality, well evaluated professional networking and learning event for members and the wider national and international infection prevention and control community.

Branches and Special Interest Groups

IPS has 14 regional branches and 8 Special Interest Groups (SIGs).

Branches **Special interestgroups **
East of England Ambulance
Ireland Audit & surveillance
London South Built environment
North East Care home
North London Community& healthprotection
North West IV
Northern Ireland Sustainability
Scotland Veterinary
South West
Trent
Wales
Wessex
West Midlands
Yorkshire

International Engagement Network (IEN)

The IEN focuses on increasing international IPS membership and providing support/resources to infection prevention practitioners collaborating/working in resource limited countries.

Objectives and activities

The objects of the charity are to promote the advancement of education in IPC for the benefit of the whole community and in particular the provision of expert advice and opinion, educational development, training courses, accreditation schemes, educational materials, meetings and conferences.

The policy of the charity continues to be to seek further development of the education agenda of the Society and better dissemination of the information through a variety of promotional vehicles, including a three-day national conference, one day national conferences for specific interest groups, local branch conferences, plus bespoke events across the UK.

SIGs are supported by the Society and are seen as an area of future development in the provisions of good infection prevention and control practice in specialist areas.

Both education, research and development grants are available as benefits to the IPS membership. The Society also provided eleven funded places at the 2024 IPS national conference to members (including two international members), and additional conference places were offered for regional members and some branch and SIG officers via local branch and SIG funding.

Public benefit

The Society benefits the public and patients primarily through supporting its members and the wider infection prevention control (IPC) community to improve IPC knowledge and practice, in order to improve patient care.

Page 5

Infection Prevention Society Trustees’ annual report

In this report we explain how we have utilised our charitable funds to support the education of healthcare practitioners via a programme of national and regional conferences and events, the development of educational resources and the publication of our journal, The Journal of Infection Prevention (JIP).

The Society has referred to the Charity Commission’s guidance on public benefit when reviewing its aims and objectives and in planning for future activities. The Trustees confirm that the IPS has complied with its duty to have regard for the guidance on public benefit published by the Charity Commission on exercising its powers and duties.

Summary of achievements and performance

Our new strategy – Working together to prevent infection – was launched in September 2024.

Our 2024 – 2027 strategic plan revolves around four key goals that will shape everything we do over the three years:

Support: Empowering our members to deliver the highest quality and safest care.

Improve: Advancing evidence-based infection prevention and control (IPC) practices, surveillance, and care across all health and care settings.

Engage: Ensuring equitable access and support for a diverse and multidisciplinary workforce in all health and care settings.

Impact: Influencing and shaping IPC education and policy to drive positive change

To achieve our goals, we will focus on three key pillars:

Inclusion: Engage with members, healthcare communities, policymakers, and people receiving care to ensure IPS is a trusted source of IPC information and is inclusive of all voices.

Progress: Ensure our activities are well-researched, planned, resources, and supported by our Branches, SIGs, and business groups, with a clinical and professional approach.

Sustainability: Address environmental impacts, support of the IPC workforce, and maintain good governance to ensure the IPS’s long-term viability.

As part of our strategy, we are also committed to continue to develop and embed our EDI strategy to help us achieve our goals.

The report summarises the activity of the Society, activity that is maintained by our Branches, Business Groups, SIGs and individual members. All of us act together to support the Society’s current vision of a world where no person is harmed by a preventable infection.

On the 1 August 2024, the Society moved from being operationally managed by a contracted secretariat company, to being operationally supported and managed by its own staff team.

At the forefront of the IPS remains our members. We continue to have a strong and engaged membership and have over 2,100 members across the world (at the end of June 2025). The launch of our new Veterinary SIG has seen us gain members from that field of IPC.

To support the dissemination of knowledge, our activities and to provide a platform for our members to engage with each other, we redeveloped the IPS website to meet our members’ needs. In addition, we developed a new membership management platform .

Membership of a professional society of peers and colleagues helps to foster networking and creativity; and the resources we provide to our members, help us all to deal with the pressures in our working lives, and develop us as practitioners and experts in our field. This year we have continued to review and add to resources available on the learning platform and website.

Our main networking and knowledge-exchange platform is our annual Conference which was held in Birmingham in September 2024. With 64 speakers from around the globe, the event attracted 548 delegates and 53 exhibiting companies over 3 days.

Page 6

Infection Prevention Society Trustees’ annual report

The Society’s Journal of Infection Prevention is an international journal focusing on research and innovation in infection prevention and control which aims to advance the evidence base in infection prevention and communicable disease prevention and control and provide a publishing platform for all health professionals working in the field. An external publishing consultancy is used to manage the journal administration to enable the editors to focus on the strategic development of JIP.

In February 2024 we held our first Industry Partnerships and Insight Event. This event, organised by our Corporate Advisory Group, reflects our new approach to working more closely with our corporate partners and members. At the event we unveiled our new Corporate Partnership Framework, developed in direct response to the valuable feedback we’ve received from our corporate members. This framework represents a fresh, revitalised approach to how we can work together more closely, with a shared focus on working together to prevent infection.

We continued the ‘OneTogether’ partnership with other professional societies and sponsored by Solventum. The OneTogether Expert Conference was held on the 6 March 2025 in Birmingham and was dedicated to reducing the risk of surgical site infections.

The Device Related Infection Prevention Practice (DRIPP) collaborative continues, working with other likeminded organisations to focus on prevention of device related infections, supported with an unrestricted educational grant from BD. With two working groups; vascular access and urinary catheters, we have produced evidence-based practical resources which are freely available to download from the DRIPP website. In October 2024, we held the 4th DRIPP workshop attended by over 80 healthcare professionals where we shared the latest DRIPP resources, discussed how these can be used in practice and provided an interactive session on change management. In addition, a series of webinars were delivered.

The Vessel Health and Preservation (VHP) is an ongoing project led by the IPS in collaboration with the National Infusion and Vascular Access Society and Medusa supported with an educational grant from Teleflex. The VHP2020 provides an evidence-based framework for vascular access which includes initial and continued assessment for device selection. The VHP resources, including a link to a web-based toolkit are available from the IPS website. The VHP2020 project was presented at a Symposium in Belfast in May 2024 and a poster was presented at the NIVAS Conference in June 2024.

As part of the Environment, Cleaning and Decontamination (ECD) educational pillar, supported by Essity/Tork and Sodexo, we held a one-day conference ‘IPC: Shaping the Future of the Built Environment’ on 20 March 2024 in Northampton.

In response to our members’ needs, the Research and Development Committee hosted a Built Environment webinar series. The October 2024 webinar saw Alyson Prince present on ‘Water and Lessons Learnt’, Paul Weaving spoke on the ‘Current Challenges and Lessons Learnt’ at the December 2024 webinar and Professor Elaine Cloutman-Green focussed on ‘Understanding the Environmental Risk’ at the January 2025 webinar.

Our IV Forum Special Interest Group held a series of webinars through the year on topics: ‘Sustainability’, ‘MARSI overview’, ‘Preventing catheter related blood stream infection’, and ‘Critical Quality Improvement Programme’. They also continued the Vessel Health and Preservation work.

The Ambulance Special Interest Group undertook a national project to improve sharps safety with all NHS Ambulance Services participation nationally; and delivered a number of pathogen specific education sessions (H5N1, Human metapneumovirus).

This year the Audit and Surveillance Specialist Interest Group have worked closely with the IV Forum Special Interest Group and the DRIPP Collaborative to support the development and pilot testing of data collection and data visualisation tools:

Page 7

Infection Prevention Society Trustees’ annual report

We launched our Veterinary Special Interest Group in January 2025 in response to requests from current members, helping us venture into a new area of expertise with the potential to increase our membership.

Eleven branch events were held across the UK either in person or virtually, addressing our members’ needs to make our events more accessible for all.

In summary, over the past year, the IPS has undergone transformative changes, evolving into an organisation that is clinically led by its volunteers, and professionally managed by its staff team, to ensure we are well positioned for the future.

Future developments

During the forthcoming year we are focussing on our Year 1 priorities of our 2024 – 2027 Strategic Plan:

Membership

After a thorough review, the decision was made that we would make some adjustments to our membership fees, which took effect from the 1 January 2025. It is important to note that this is the first time since 2006 that we have increased our fees, despite inflationary pressures and increased costs in delivering our services. We have carefully benchmarked our fees against other societies and believe that these changes will allow us to continue enhancing the benefits we offer to our members, such as improving access to resources, expanding educational opportunities, and amplifying the impact of our collective work.

Total membership on 31 March 2025 was 2,175 members demonstrating decrease of 244 members against the previous financial year. Although this drop in membership is of concern, it is too early to assess whether this is a direct result of the increase in membership fee. Corporate membership (which is included in the total membership figure) during the financial period remained steady at 41 though it is worth noting that this has since increased to 43 since the start of the new financial year with 2 of our corporate members taking up our new tiered levels of corporate partnership packages. Our new strategy includes activities to grow and engage the IPC community, with a view to increasing our membership across all categories over the next three years.

Page 8

Infection Prevention Society Trustees’ annual report

Financial Review

Financial management is one of the many critical functions of an effective Society to ensure the Society operates a robust governance structure in meeting its obligations.

IPS activity has continued across a range of endeavours and continues to grow in an ever-challenging healthcare arena. In 2024 the Board of Trustees reviewed and approved a revised scheme of delegation, clarifying approval procedures for expenditure and reflecting the revised operating structure once the staff team were in place.

The Society’s activities produced a deficit before movements on investments of £216,035 (2024: £18,155). The overall deficit after accounting for changes in the value of investments was £227,175 (2022 £7,364).

The total funds for the Society amounted to £703,398 (2024: £930,573) comprising general unrestricted reserves of £676,846 (2024: £919,486), designated funds of £26,552 (2024: £11,087).

The Society sold the majority of its investments held by King & Shaxon during the year to ensure the Society had sufficient working capital held in deposit earning bank accounts, readily available for the Society to call upon. The value of the remainder of the investment portfolio was £281,189 (2024: £510,214) These investments represent funds held for the development of the Society’s activities in the medium to long term at a level of funds in excess of the reserves levels set by the trustees.

Income

Membership income fell slightly in 2025 to £196,896 (2024: £202,385), consistent with a decrease in membership numbers reported above.

Income for the annual conference decreased to £499,911 (2024: £651,803). The Trustees took the decision to move from a three day conference to a two day conference in 2025 to reflect feedback that three days was difficult to take due to the pressures within the NHS. This also reflected a tightening of budgets for sponsors and exhibitors.

Education income also fell to £111,725 (2024: £133,052)

It is the expectation of the BoT that the engagement of a staff team will ultimately enable to Society to pursue new, income generating, activities that will both facilitate the achievement of our charitable objectives, offset the costs associated with the staff team and also generate an annual surplus income. Activities include the development of income generating events, educational resources and partnerships.

Expenditure

Overall expenditure increased to £1,035,066 (2024 £1,016,241), this included the transition of operational activities away from an Association Management Company to a staff team. This enables staff to focus on membership, events and finances to support the growth of the Society.

The Trustees note that income generated from the annual conference and education did not cover the costs of such events and will focus on ensuring these activities return a surplus to the Society.

Remuneration policy is based in offering a market level employment package, including pension, benchmarked against salaries for remote charity employees with the skills required by the Society. These are reviewed annually and approved by the Trustees, after adjustment for inflation.

Staffing and administration costs are allocated across the strategic activity streams to reflect the proportion of time and cost incurred. This is reassessed each year in line with actual activities and usage. Governance costs are directly allocated or apportioned on an assessment basis.

Page 9

Infection Prevention Society Trustees’ annual report

Reserves Policy

The Trustees recognise the need to hold reserves to enable financial stability and ensure adequate working capital availability. In arriving at the appropriate level of reserves, the Trustees have considered the following:

The Trustees consider reserves are required to fund:

The policy therefore requires the Society to maintain reserves of circa £400,000 made up as follows:

The Trustees also acknowledge that there may be a need from time to time to ensure that reserves also cover other significant liabilities not already reflected in the reserve calculations that could place a material claim on reserves.

The estimated level of general unrestricted reserves at 31 March 2025 is £676,846, which is above the required level. The level of reserves is continually monitored by the Trustees.

Investment Powers and Policy

Under The Articles of Association, the Society has the power to invest without restriction.

The Society’s investment strategy is reviewed annually by the BoT to ensure that it is relevant and meets the requirements of the Society.

In December 2024, BoT agreed to divest in one of the two investment funds to ensure the Society had sufficient working capital held in short-term readily available deposit accounts. The majority of the portfolio was sold and the funds transferred shortly after the financial year end.

Risk Management

The Trustees operate a robust governance structure that enables charitable aims and objectives to be achieved. This includes a managed risk register which is reviewed at each board meeting.

The IPS Board identified the level of potential risk and appropriate actions to mitigate the risk during scheduled meetings, and the business planning and financial forecasting process. The Board of Trustees recognises the financial risk and is fully aware that the Society needs to closely examine its income and expenditure.

Whilst a new financial strategy is still to be developed following the finalisation of the organisation strategy, the Board of Trustees remain focussed on achieving a balanced budget, while continuing to improve member access to education and support.

The Audit and Finance committee have continued to meet during 2024/25 to scrutinise the financial activity of the Society and report their findings to the Board.

Page 10

Infection Prevention Society Trustees’ annual report

In addition, the Board of Trustees review the strategies on an annual basis, to ensure that it remains relevant to its stated purpose, takes account of any changes in context and alignment to the Articles of Association, identified risks and Board Business plan/priority activities.

Membership and conference income are monitored regularly to highlight potential income reductions and plans put in place to mitigate identified problem areas.

Remuneration policy for Trustees’ employers

As outlined in the Articles of Association, Trustees do not receive remuneration for their role, nor does the society pay remuneration to any volunteer of IPS or their employers.

Statement of Trustees’ Responsibilities

The Trustees (who are also the directors of the Infection Prevention Society for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under that law the Trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charity and the income and expenditure of the charity for that period.

In preparing these financial statements, the Trustees are required to:

Select suitable accounting policies and then apply them consistently. Observe the methods and principles in the Charities SORP.

Make judgements and accounting estimates that are reasonable and prudent.

State whether applicable accounting standards and statements of recommended practice have been followed, subject to any material departures disclosed and explained in the financial statements; and Prepare the accounts on the going concern basis unless it is inappropriate to presume that the charity will continue in operation.

The Trustees are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

there is no relevant audit information of which the charitable company’s auditor is unaware; and the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the reparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Approved by order of the Members of the Board of Trustees and signed on its behalf by:

Sally Palmer, Treasurer Date 2 December 2025

Page 11

Infection Prevention Society Independent auditors’ report to the trustees

Opinion

We have audited the financial statements of Infection Prevention Society for the year ended 31 March 2025 which comprise the Statement of Financial Activities, the Balance Sheet, Cash Flow Statement and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information we are required to report that fact.

We have nothing to report in this regard.

Page 12

Infection Prevention Society Independent auditors’ report to the trustees

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees’ Annual Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the Trustees’ Responsibilities Statement set out on page 11, the trustees (who are also directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative to do so.

Auditor’s responsibilities for the audit of the financial statements

We have been appointed as auditors under the Companies Act 2006 and report in accordance with regulations made under that Act.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Page 13

Infection Prevention Society Independent auditors’ report to the trustees

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud are detailed below.

Identifying and assessing risks related to irregularities:

We assessed the susceptibility of the charitable company’s financial statements to material misstatement and how fraud might occur, including through discussions with the trustees, discussions within our audit team planning meeting, updating our record of internal controls and ensuring these controls operated as intended. We evaluated possible incentives and opportunities for fraudulent manipulation of the financial statements. We identified laws and regulations that are of significance in the context of the charitable company by discussions with trustees and updating our understanding of the sector in which the charitable company operates.

Laws and regulations of direct significance in the context of the charitable company include The Companies Act 2006, and guidance issued by the Charity Commission for England and Wales.

Audit response to risks identified:

We considered the extent of compliance with these laws and regulations as part of our audit procedures on the related financial statement items including a review of financial statement disclosures. We reviewed the charitable company’s records of breaches of laws and regulations, minutes of meetings and correspondence with relevant authorities to identify potential material misstatements arising. We discussed the charitable company’s policies and procedures for compliance with laws and regulations with members of management responsible for compliance.

During the planning meeting with the audit team, the engagement partner drew attention to the key areas which might involve non-compliance with laws and regulations or fraud. We enquired of management whether they were aware of any instances of non-compliance with laws and regulations or knowledge of any actual, suspected or alleged fraud. We addressed the risk of fraud through management override of controls by testing the appropriateness of journal entries and identifying any significant transactions that were unusual or outside the normal course of business. We assessed whether judgements made in making accounting estimates gave rise to a possible indication of management bias. At the completion stage of the audit, the engagement partner’s review included ensuring that the team had approached their work with appropriate professional scepticism and thus the capacity to identify non-compliance with laws and regulations and fraud.

There are inherent limitations in the audit procedures described above and the further removed noncompliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Page 14

Infection Prevention Society Independent auditors’ report to the trustees

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Kenneth McDowell (Senior Statutory Auditor) 9 Haymarket Square For and on behalf of Saffery LLP Edinburgh EH3 8RY

Statutory Auditors

Date: 5 December 2025

Saffery LLP is eligible to act as an auditor in terms of section 1212 of the Companies Act 2006.

Page 15

Infection Prevention Society Statement of financial activities (incorporating the income and expenditure account) For the year ended 31 March 2025

All funds are unrestricted
Notes
Income from:
Donations
Charitable activities
1
Investments
2
Total income
Expenditure on:
Raising funds
3
Charitable activities
4
Total expenditure
Net (losses)/gains on investments
12
Net deficit for the year
Reconciliation of funds
Total funds brought forward
Net movement in funds
Total funds carried forward
16		 Total
funds
2025
Total funds
2024
£
£
336
-
808,532
988,065
16,355
16,252
825,223
1,004,317
(6,192)
(6,231)
(1,035,066) (1,016,241)
(1,041,258)(1,022,472)
(11,140)
10,791
(227,175)
(7,364)
930,573
937,937
(227,175)
(7,364)
703,398
930,573

The Statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 19 to 27 form part of these financial statements. All income and expenditure derives from continuing activities

Page 16

Infection Prevention Society Balance sheet As at 31 March 2025

Registered number: 06273843

Notes 2025 2025 2024 2024
£ £ £ £
Fixed assets
Tangible assets 10 5,039 2,112
Intangible assets 11 21,513 8,975
Investments 12 281,189 510,214
Total fixed assets 307,741 521,301
Current assets
Debtors 13 252,659 405,159
Cash at bank and in hand 554,772 327,235
807,431 732,394
Creditors: amounts falling due within
one year		 14 (411,774) (323,122)
Net current assets 395,657 409,272
Total net assets 703,398 930,573
Charity funds
Unrestricted funds 16
General 676,846 919,486
Designated 26,552 11,087
Total funds 703,398 930,573

The trustees acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

Sally Palmer, Treasurer Date 2 December 2025

The notes on pages 19 to 27 form part of these financial statements

Page 17

Infection Prevention Society Statement of cash flows For the year ended 31 March 2025

Cash flows from operating activities
Net expenditure (income) for the year
Adjustments for:
Depreciation charge
Amortisation charge
Losses/(gains) on investments
Investment income
Decrease/(increase) in debtors
Increase/(decrease) in creditors
Net cash generated by operating activities
Cash flows from investing activities
Purchase of fixed assets
Investment income
Proceeds from sale of investments
Purchase of investments
Movement in cash held with investment managers
Net cash provided by investing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year		 2025
2024
£
£

(227,175)
(7,364)
1,944
621
8,975
6,335
11,140
(10,791)
(14,308)
(12,467)
152,500
(228,065)
88,652
(178,729)
21,728
(430,460)
(26,384)
-
14,308
12,467
359,525
118,678
(184,674)
(111,573)
43,034
(13,341)
205,809
6,231
227,537
(424,229)
327,235
751,464
554,772
327,235

The notes on pages 19 to 27 form part of these financial statements.

Page 18

Infection Prevention Society Accounting policies

Legal Status

The Society is a company limited by guarantee and is registered with the Charity Commission in England and Wales (Charity Registration Number 1039236) and the Registrar of Companies (Company Registration Number 02940178) in England and Wales.

The Society is governed by a Trustee Board comprising 11 members, the President (who shall be a member) the Chair, the Treasurer, up to four further individuals appointed by the Trustees (who shall not be members), and a further four members appointed in accordance with the Regulations. In the event of the Society being wound up, the liability in respect of the guarantee is limited to £1 per member of the Council

The address of the registered office is given in the Society information on page 2 on these financial statements. The nature of the Society's operations and principal activities are listed in the Trustees Report.

Basis of preparation of the financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities in preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Companies Act 2006.

The financial statements have been prepared on the historical cost basis of accounting and on the going concern basis.

Judgements and key sources of estimation uncertainty are set out within note m) of the Accounting Policies.

Infection Prevention Society meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

Preparation of the financial statements on a going concern basis

The Society’s financial activities, its current financial position and factors likely to affect its future development are set out in the Trustees Annual Report. On this basis the Trustees have a reasonable expectation that the Society has adequate resources to continue in operational existence for the foreseeable future, being a period of at least one year from the date of approval of these financial statements. For this reason, it continues to adopt the going concern basis in the financial statements.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

a) Income

Income, excluding VAT, is recognised one the Society has entitlement to the income, it is probable the charity will receive that income, and the amount can be quantified with reasonable accuracy.

Incoming resources in respect of specific charitable activities or projects are included in the period in which the project or activity is undertaken.

Other income is recognised in the period in which it is receivable and to the extent the services have been provided or on completion.

Page 19

Infection Prevention Society Accounting policies

b) Expenditure

Expenditure is recognised, inclusive of any VAT that cannot be recovered, once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity, and the costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources.

Expenditure on raising funds includes all expenditure incurred by the Society to raise funds for its charitable purposes and includes costs of all fundraising activities.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Society's objectives, as well as any associated support costs.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

c) Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Society; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

d) Tangible fixed assets and depreciation

Tangible fixed assets costing £500 or more are capitalised and recognised when future economic benefits are probable and the cost of value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition are included in the measurement of cost.

Fixed assets are assessed at the end of each financial year for permanent impairment in value.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives on the following basis:

Computers and office equipment 33% straight line Fixtures and fittings 25% reducing balance Badge of office Nil

e) Intangible fixed assets

Intangible fixed assets costing £500 or more are capitalised and recognised when future economic benefits are probable, and the cost or value of the asset can be measured reliably.

Intangible fixed assets are initially recognised at cost. After recognition, under the cost model, intangible fixed assets are measured at cost less accumulated amortisation and any accumulated impairment losses. All costs incurred to bring an intangible fixed asset into its intended working condition are included in the measurement of cost.

Fixed assets are assessed at the end of each financial year for permanent impairment in value.

Amortisation is charged so as to allocate the cost of intangible fixed assets less their residual value over their estimated useful lives on the basis of 33% straight line.

Page 20

Infection Prevention Society Accounting policies

f) Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently valued at market value at the balance sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘gains/(losses) on investments’ in the Statement of Financial Activities.

g) Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

h) Cash and cash equivalents

Cash at bank includes cash and short-term highly liquid investments with a short term maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

i) Liabilities and provisions

Liabilities are recognised when there is an obligation at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Society anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.

j) Financial instruments

The Society only has financial assets and financial liabilities of a kind that qualify as basic financial instruments which are recognised at transaction value and subsequently measured at their settlement value.

k) Pensions

The Society operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Society to the fund in respect of the year.

l) Funds

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objective of the Society and which have not been designated for other purposes. Designated funds comprise the value of tangible and intangible fixed assets. Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Society for particular purposes.

m) Critical accounting estimates and areas of judgement

In the application of the Society’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and judgements are continually evaluated and based on historical experience and other factors, including expectations of future events that are considered to be relevant and reasonable under the circumstances. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revision of accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

Page 21

Infection Prevention Society Notes to the financial statements for the year ended 31 March 2025

1 Income from charitable activities

Membership subscriptions
Annual conference
Education
Publications
2 Investment income
Dividends and interest receivable
Bank interest receivable
3 Investment management costs
Investment management fees		 2025
2024
£
£
196,896
202,385
499,911
651,803
111,725
133,052
-
825
808,532
988,065
2025
2024
£
£
14,308
12,467
2,047
3,785
16,355
16,252
2025
2024
£
£
6,192
6,231

4 Cost of charitable activities by activity type

Cost of charitable activities by activity type
Membership
Annual conference
Education
Membership
Annual conference
Education		 Activities
undertaken
directly
Grant
funding of
activities
Support
costs
Total
funds
2025
2025
2025
2025
£
£
£
£
80,007
-
112,865
192,872
543,683
-
84,649
628,332
116,517
12,696
84,649
213,862
740,207
12,696
282,163
1,035,066
Activities
undertaken
directly
Grant
funding of
activities
Support
costs Total funds
2024
2024
2024
2024
£
£
£
£
69,138
-
114,296
183,434
593,082
-
85,723
678,805
67,905
375
85,722
154,002
730,125
375
285,741
1,016,241

Page 22

Infection Prevention Society Notes to the financial statements for the year ended 31 March 2025

5 Analysis of support costs

Staff costs
Administration
Association Management
Travel and subsistence
Depreciation
Other
Governance
6 Net income/expenditure for the year
This is stated after charging:
Depreciation
Amortisation
Auditor’s remuneration		 2025
2024
£
£
76,798
-
89,353
73,023
44,414
69,099
15,279
24,556
1,944
621
24,383
83,883
29,992
34,559
282,163
285,741
2025
2024
£
£
1,944
621
8,975
6,335
25,750
28,850

7 Trustees’ remuneration and expenses

During the year, no Trustee received any remuneration or other benefits (2024: £nil). Expenses for travel, accommodation and subsistence totalling £4,761 were reimbursed to or paid for 13 Trustees (2024: £3,532 to 7 trustees).

8 Staff costs

Staff costs
Wages and salaries
Social security costs
Pension costs		 2025
2024
£
£
125,324
-
7,774
-
5,550
-
138,648
-

The average number of persons employed by the Society during the year was as follows:

Charitable activities
Support functions		 2025
2024
2
-
2
-
4
-

There were no employees whose employee benefits (excluding employer pension costs) exceeded £60,000.

The total amount of employee benefits received by Key Management Personnel, including Employers National Insurance contributions and employers pension contributions, is £35,634 (2024 - nil). The Society considers its Key Management Personnel to be the Trustees and the Chief Executive.

Page 23

Infection Prevention Society Notes to the financial statements for the year ended 31 March 2025

9 Taxation

The charity’s activities fall within the exemption of afforded by the provisions of the Income and Corporation Taxes Act 1998. Accordingly, there is no taxation charge in these accounts.

10 Tangible fixed assets

Cost
At 1 April 2024
Additions
Disposals
At 31 March 2025
Depreciation
At 1 April 2024
Charge for the period
Disposals
At 31 March 2025
Net book value:
At 31 March 2025
At 31 March 2024		 Badge of
office
Computer
& office
equipment
Fixtures &
fittings
Total
£
£
£
£
1,250
1,782
1,046
4,078
-
4,871
-
4,871
-
(835)
(1,046)
(1,881)
1,250
5,818
-
7,068
-
1,046
920
1,966
-
1,818
126
1,944
-
(835)
(1,046)
(1,881)
-
2,029
-
2;029
1,250
3,789
-
5,039
1,250
736
126
2,112

11 Intangible assets

Intangible assets comprise the website and CRM
Cost
At 1 April 2024
Additions
Disposals
At 31 March 2025
Amortisation
At 1 April 2024
Charge for the period
Disposals
At 31 March 2025
Net book value
As at 31 March 2025
As at 31 March 2024		 Total
£
31,675
21,513
-
53,188
22,700
8,975
-
31,675
21,513
8,975

Page 24

Infection Prevention Society Notes to the financial statements for the year ended 31 March 2025

12 Investments

12 Investments
Valuation
At 1 April 2024
Additions at cost
Disposal proceeds
(Loss)/profit on disposals
Net gain/(loss) on revaluation for the year
Movement in cash held with investment managers
At 31 March 2025
Historical cost at 31 March 2025
Analysis of investments at 31 March 2025 between funds:
UK listed equities
UK bonds
Overseas equities
Overseas bonds
Other listed financial instruments
Cash held with investment managers
13 Debtors
Trade debtors
Other debtors
Prepayments
14 Creditors: Amounts falling due within one year
Trade creditors
Other taxation and social security
Other creditors
Accruals and deferred income		 2025
2024
£
£
510,214
493,187
184,674
111,573
(359,525)
(118,679)
(9,987)
3,919
(1,153)
6,873
(43,034)
13,341
281,189
510,214
281,701
484,102
48,695
150,636
45,463
121,045
135,374
118,187
14,763
32,811
32,591
40,220
4,303
47,315
281,189
510,214
2025
2024
£
£
160,195
193,312
27,685
30,601
64,779
181,246
252,659
405,159
2025
2024
£
£
64.495
56,392
17,855
-
84,518
33,448
244,906
233,282
411,774
323,122

Page 25

Infection Prevention Society Notes to the financial statements for the year ended 31 March 2025

15 Deferred income
Deferred income relates to subscriptions, conference and other event
income paid in advance for the next financial year
At 1 April
Income deferred during the year
Amounts released from previous periods
At 31 March
16 Statement of funds
At 1 April
2024
Income Expenditure
Investment
gain/(loss)
£
£
£
Unrestricted funds
General
919,486
825,223
(1,041,258)
(11,140)
Designated
11,087
-
-
-
Total funds
930,573
825,223
(1,041,258)
(11,140)
At 1 April
2023
Income ExpenditureInvestment
gain/(loss)
£
£
£
Unrestricted funds
General
919,894
1,004,317
(1,022,472)
10,791
Designated
18,043
-
-
-
937,937
1,044,317
(1,022,472)
10,791		 15 Deferred income
Deferred income relates to subscriptions, conference and other event
income paid in advance for the next financial year
At 1 April
Income deferred during the year
Amounts released from previous periods
At 31 March
16 Statement of funds
At 1 April
2024
Income Expenditure
Investment
gain/(loss)
£
£
£
Unrestricted funds
General
919,486
825,223
(1,041,258)
(11,140)
Designated
11,087
-
-
-
Total funds
930,573
825,223
(1,041,258)
(11,140)
At 1 April
2023
Income ExpenditureInvestment
gain/(loss)
£
£
£
Unrestricted funds
General
919,894
1,004,317
(1,022,472)
10,791
Designated
18,043
-
-
-
937,937
1,044,317
(1,022,472)
10,791
2025
2024
£
£
215,282
280,983
220,790
215,282
(215,282)
(280,983)
220,790
215,282


Transfers
At 31
March 2025
£
£

(15,465)
676,846

15,465
26,552
930,573
825,223
(1,041,258)
(11,140)
-
703,398
At 1 April
2023
Income ExpenditureInvestment
gain/(loss)
£
£
£
919,894
1,004,317
(1,022,472)
10,791
18,043
-
-
-

Transfers
At 31
March 2024
£
£

6,956
919,486

(6,956)
11,087
937,937
1,044,317
(1,022,472)
10,791
-
930,573

Designated funds comprise the value of tangible and intangible fixed assets

17 Analysis of net assets between funds

General
Designated
Total funds		 General
Designated		 Total funds
funds 2025
funds 2025
2025		 funds 2024
funds 2024		 2024
£
£
£		 £
Fixed assets 507,189 26,552 533,741 510,214 11,087 521,301
Current assets 581,431 - 581,431 732,394 - 732,394
Creditors falling due
within one year		 (411,774)
-		 (411,774) (323,122)
-		 (323,122)
678,846 26,552 703,398 919,486 11,087 930,573
Analysis of changes in net cash
At 1 April At 31 March
2024 Cash flows 2025
£ £ £
Cash at bank and in hand 327,235 1,537 328,772

18 Analysis of changes in net cash

Page 26

Infection Prevention Society Notes to the financial statements for the year ended 31 March 2025

19 Balances held as agent

Balances held as agent
Funds administered by the Society in accordance At 1 April Funds At 31 March
with instructions received. 2024 received Funds paid 2025
£ £ £ £
OneTogether - 100,000 (38,760) 61,240

20 Pension commitments

The Society operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the Society in an independently administered fund. The pension cost recognised as an expense in the year was £5,550 (2024: nil). There were £1,059 of outstanding pension contributions payable to the fund at the balance sheet date (2024: nil).

21 Capital commitments

The Society had capital commitments for intangible fixed assets at 31 March of £13,237 (2024: £nil).

22 Related party transactions

Trustee and Key Management Personnel transactions are detailed in notes 7 and 8.

There were no other related party transactions during the year.

Page 27